Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Continuous Flow Chemistry. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Discover a novel, high-yield synthesis method for E-type benzofulvene derivatives with excellent stereoselectivity, reducing production costs and time for pharmaceutical and agrochemical applications.
Eliminate explosive peroxides and heavy metals in 1,2,4-triazole synthesis. Our CDMO expertise ensures high-yield, scalable production with 99%+ purity for drug development.
Solve high-temperature synthesis challenges with this metal-free photocatalytic method. Achieve 89% yield, reduced costs, and simplified purification for your API production.
Discover how metal-free amide synthesis reduces production costs and safety risks for pharmaceutical intermediates. Scale-ready, high-yield process with 99% purity. Contact us for custom synthesis solutions.
Discover how glucose-derived 3-trifluoromethyl-1,2,4-triazole synthesis eliminates anhydrous/oxygen-free requirements, cuts production costs, and ensures scalable API manufacturing for pharma R&D and procurement teams.
Solve azaspiro[4,5]-tetraenone synthesis challenges with metal-free, scalable route. Reduce costs, avoid heavy metals, and ensure 99%+ purity for pharma intermediates.
Solve low enantioselectivity & high catalyst cost in alpha-hydroxy-beta-keto ester production. 97% ee, 95% yield, 5-25 mol% catalyst. Scale to 100 MT/yr with NINGBO INNO PHARMCHEM.
Discover how rhodium-catalyzed C-H activation enables cost-effective, gram-scale production of trifluoromethylated indole intermediates with high functional group tolerance for drug development.
Discover how cobalt-catalyzed C-H activation enables efficient indole carboxamide production for pharma R&D. Reduce costs and supply chain risks with scalable, high-yield routes.
Discover how recent photocatalytic synthesis of beta-chloroesters eliminates pre-functionalization needs, reduces supply chain risks, and achieves >60% yields for pharmaceutical intermediates.
Discover how novel C-H activation methods for polysubstituted isoquinolines reduce catalyst costs and improve yield in pharmaceutical synthesis. Contact us for custom manufacturing.